Genoray Co., Ltd. (KOSDAQ:122310)
3,820.00
-150.00 (-3.78%)
At close: Jun 1, 2026
Genoray Market Cap
Genoray has a market cap or net worth of 48.22 billion as of May 29, 2026. Its market cap has decreased by -31.42% in one year.
Market Cap
48.22B
Enterprise Value
62.72B
Revenue
108.27B
Ranking
n/a
PE Ratio
221.52
Stock Price
3,820.00
Market Cap Chart
Since May 28, 2018, Genoray's market cap has decreased from 150.47B to 48.22B, a decrease of -67.95%. That is a compound annual growth rate of -13.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 48.22B | -4.57% |
| Dec 30, 2025 | 50.53B | -27.84% |
| Dec 30, 2024 | 70.03B | -26.75% |
| Dec 28, 2023 | 95.60B | -11.63% |
| Dec 29, 2022 | 108.18B | -23.55% |
| Dec 30, 2021 | 141.51B | 1.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| May 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SELVAS Healthcare | 90.14B |
| Remed | 89.32B |
| Hironic | 83.24B |
| Dynamic solution | 71.68B |
| QuantaMatrix | 63.02B |
| DRGEM | 55.35B |
| Noul Co.,Ltd. | 50.01B |
| JPI Healthcare | 44.72B |